EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1

In Vitro Diagnostic Medical Devices Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998

This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.

Last updated 17 lipnja 2024. Database contains 4821 unique substances/entries.
Filter the list

A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C32 and produces a finished oil with a viscosity in the order of 17cSt to 23cSt at 40°C (104°F).
309-875-6
101316-70-5
Carc. 1B
A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C35 and produces a finished oil with a viscosity in the order of 37cSt to 44cSt at 40°C (104°F).
309-876-1
101316-71-6
Carc. 1B
A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C24 through C50 and produces a finished oil with a viscosity in the order of 16cSt to 75cSt at 40°C (104°F).
309-877-7
101316-72-7
Carc. 1B
A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of vacuum distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C25 and produces a finished oil with a viscosity in the order of 32cSt to 37cSt at 100°C (212°F).
309-874-0
101316-69-2
Carc. 1B
CGA 184699
410-690-9
103055-07-8
Skin Sens. 1
202-987-5
101-90-6
Carc. 1B; Muta. 2; Acute Tox. 3; Acute Tox. 4; Skin Irrit. 2; Eye Irrit. 2; Skin Sens. 1
203-577-9
108-39-4
Acute Tox. 3; Skin Corr. 1B
PRODUCT 5899
404-150-1
17092-80-7
Skin Irrit. 2
203-584-7
108-45-2
Muta. 2; Acute Tox. 3; Eye Irrit. 2; Skin Sens. 1
203-583-1
108-44-1
Acute Tox. 3; STOT RE 2
203-576-3
108-38-3
Flam. Liq. 3; Acute Tox. 4; Skin Irrit. 2
DUPLOSAN-DP-MAGNESIUM
413-360-2
164058-21-3
Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
241-022-2
16949-65-8
Acute Tox. 3
235-023-7
12057-74-8
Water-react. 1; Acute Tox. 2; Acute Tox. 3; Acute Tox. 1
204-497-7
121-75-5
Acute Tox. 4; Skin Sens. 1
203-742-5
110-16-7
Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1
203-571-6
108-31-6
Acute Tox. 4; STOT RE 1; Skin Corr. 1B; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1A
203-703-2
109-77-3
Acute Tox. 3
235-654-8
12427-38-2
Repr. 2; Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
215-202-6
1313-13-9
Acute Tox. 4
239-924-6
15825-70-4
Unst. Expl.
239-924-6
15825-70-4
Expl. 1.1
240-539-0
16484-77-8
Acute Tox. 4; Eye Dam. 1
205-275-2
137-05-3
Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
204-987-0
130-37-0
Eye Irrit. 2; Skin Irrit. 2
432-140-7
110235-47-7
Carc. 2
205-769-8
150-76-5
Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
203-604-4
108-67-8
Flam. Liq. 3; STOT SE 3
600-533-4
104206-82-8
Repr. 2; STOT RE 2
604-167-6
139968-49-3
Repr. 2; Lact.; STOT RE 2
205-293-0
137-42-8
Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1
603-031-3
125116-23-6
Repr. 2; Acute Tox. 4
204-817-5
126-98-7
Flam. Liq. 2; Acute Tox. 3; Skin Sens. 1
233-606-0
10265-92-6
Acute Tox. 2; Acute Tox. 3
202-905-8
100-97-0
Flam. Sol. 2; Skin Sens. 1
240-815-0
16752-77-5
Acute Tox. 2
241-420-6
17392-83-5
Flam. Liq. 3; Eye Irrit. 2; STOT SE 3
DISPERSE RED CLA 282
416-240-8
155522-12-6
Skin Sens. 1
JE 127
421-220-7
144740-59-0
Skin Sens. 1
LUGALVAN ES 9571
420-940-9
15768-07-7
Eye Irrit. 2; Skin Irrit. 2
MEFAT
404-130-2
105560-93-8
Eye Dam. 1; Skin Sens. 1
620-362-9
1918-18-9
Acute Tox. 4
425-190-6
119916-05-1
STOT RE 2
MAT 9460
414-080-3
117291-73-3
Acute Tox. 4
203-299-8
105-45-3
Eye Irrit. 2
203-481-7
107-31-3
Flam. Liq. 1; Acute Tox. 4; Eye Irrit. 2; STOT SE 3
FAT 40'489
413-040-2
149850-30-6
Skin Sens. 1
414-460-9
105726-67-8
Acute Tox. 4
204-317-7
119-36-8
Repr. 2; Acute Tox. 4; Skin Sens. 1B
203-475-4
107-25-5
Flam. Gas 1; Press. Gas
236-035-5
13108-52-6
Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
N 5297
419-010-5
112941-26-1
Acute Tox. 4; Eye Irrit. 2
435-500-1
152460-07-6
Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
203-624-3
108-87-2
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3
204-064-2
115-09-3
Carc. 2; Repr. 1A; Lact.; Acute Tox. 2; STOT RE 1
METHYL-TPP-CHLORID; MTPP-CHLORID
418-400-2
1031-15-8
Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1
214-446-0
1129-41-5
Acute Tox. 4
410-240-1
139528-85-1
Carc. 2; STOT RE 2
-
1314-04-1
Carc. 1A; Muta. 2; STOT RE 1; Skin Sens. 1
215-293-2
1319-77-3
Acute Tox. 3; Skin Corr. 1B
NUPORE G45-10
420-480-9
158570-99-1
Skin Irrit. 2; Skin Sens. 1
-
12673-58-4
Carc. 1A; STOT RE 1; Skin Sens. 1
238-034-5
14177-55-0
Carc. 1A; STOT RE 1; Skin Sens. 1
215-204-7
1313-27-5
Carc. 2; Eye Irrit. 2; STOT SE 3
203-083-3
103-16-2
Eye Irrit. 2; Skin Sens. 1
217-129-5
1746-81-2
Acute Tox. 4; STOT RE 2
205-766-1
150-68-5
Carc. 2; Acute Tox. 4
203-815-1
110-91-8
Flam. Liq. 3; Acute Tox. 4; Skin Corr. 1B
239-213-0
15159-40-7
Carc. 2; Eye Irrit. 2; Skin Irrit. 2
205-628-0
144-41-2
Acute Tox. 3
429-380-1
133336-92-2
Skin Sens. 1
LUPRAGEN VP 9159
401-660-6
1000-78-8
Skin Irrit. 2; Skin Sens. 1
BMS 208143-01; BTHC
429-670-6
105996-54-1
Eye Dam. 1; Skin Sens. 1
CARTASOL BRILLIANT YELLOW K-6G; CARTASOL BRILLIANT YELLOW K-6G CONC.; GIALLO BRILLANTE CARTASOL K-6G CONC.; JAUNE BRILLANT CARTASOL K-RWA 3904; RWA 3904
403-340-1
164578-09-0
Eye Dam. 1
202-831-6
100-22-1
Acute Tox. 4
AF-172; FPC 114
405-300-9
17339-60-5
Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
203-744-6
110-18-9
Flam. Liq. 2; Acute Tox. 4; Skin Corr. 1B
DIETHANOLAMIN-TRITOSYLAT
412-920-3
16695-22-0
Skin Sens. 1
203-336-8
105-83-9
Acute Tox. 3; Acute Tox. 4; Skin Corr. 1B
418-290-6
168612-06-4
Eye Irrit. 2; Skin Sens. 1
HOSTALUX VP 3481
401-410-6
10357-99-0
STOT RE 2; Skin Sens. 1
B1; N,N-DIMETHYLANILINUM TETRAKIS(PENTAFLUOROPHENYL)BORATE; TÉTRAKIS(PENTAFLUOROPHÉNYL)BORATE DE N,N-DIMÉTHYLANILINIUM
422-050-6
118612-00-3
Carc. 2; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1
F.H.D.A.
403-510-5
19247-05-3
Acute Tox. 3; STOT RE 2; Skin Sens. 1
RED REN 363
419-500-9
171599-85-2
Eye Dam. 1; Skin Sens. 1
QUESTAMIDE H
422-560-9
149591-38-8
Repr. 2; Eye Irrit. 2
LICHTSCHUTZMITTEL 1736
413-610-0
124172-53-8
Eye Irrit. 2
PFMT 1848
410-060-3
130728-76-6
Muta. 2; Skin Sens. 1
202-959-2
101-61-1
Carc. 1B
yes
CHIMASSORB 119; LOWILITE 19
401-990-0
106990-43-6
Skin Sens. 1
205-319-0
138-24-9
Acute Tox. 3
431-530-4
1380226-29-8
Skin Corr. 1A; Skin Sens. 1
205-149-7
134-62-3
Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2
204-495-6
121-72-2
Acute Tox. 3; STOT RE 2
204-826-4
127-19-5
Repr. 1B; Acute Tox. 4
yes
204-493-5
121-69-7
Carc. 2; Acute Tox. 3
423-840-3
14691-89-5
Acute Tox. 4
UM-229
407-070-5
142859-67-4
Skin Sens. 1
425-650-6
171887-03-9
Acute Tox. 4; Eye Dam. 1; Skin Sens. 1
UC-129
403-790-9
108673-51-4
Skin Sens. 1
TSD-40
413-200-1
129604-78-0
Skin Sens. 1

Export search results to: